Not Finding What You're Looking For?
Donnelley Ethics Program
Donnelley Ethics Program is a resource for the entire community who have challenges or concerns regarding the delivery of patient care and/or research.
Service
Clinical Ethics Consultations
Our ethics consultation service is committed to creating an atmosphere that encourages conflict resolution, value exploration and informed decision-making.
Page
Ethics & Educational Activities
The Donnelley Ethics Program provides a variety of educational activities for AbilityLab staff as well as members of the general public.
Page
Research Ethics Consultations
Our research ethics program gives those involved in research an opportunity to explore potential ethical issues.
Page
Statistical Terms & Use
Check out our basic review of the statistical terms used on the Rehabilitation Measures website.
Page
Parkinson's Disease & Movement Disorders
Our rehabilitation treatment plans for Parkinson's Disease & Neurologic Conditions improve the ability to move, think clearly and speak with greater volume.
Condition
Additional Outcomes Resources
Other available websites that contain assessment instrument descriptions or documents to assist you in your research.
Page
About RehabMeasures Database
Developed in collaboration between the AbilityLab and Feinberg School of Medicine with a grant from the NIH.
Page
RehabMeasures Contributors
The Database is proud to have members and contributors from university and institutions from across the globe.
Page
Pulmonary Disorders
Our Pulmonary Rehabilitation Program helps you understand the causes behind pulmonary disorders and what you can do to increase lung capacity.
Condition
At Home Workout: Lower Extremity Exercise
This routine is intended to work primarily on lower body strength and endurance. It covers most of the lower body, but not all of it. Ideally, it would be performed 2 times per week, and for 2 to 3 sets each time.
Blog
Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD
The purpose of this study is to alleviate persisting attention deficits related to mild TBI and PTSD by treating the neurocognitive system of attention.
Age Range
18-80
Clinical Trial